Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific...

Area of Science:

• Stem cell biology
• Regenerative medicine
• Proteomics and transcriptomics

Background:

• Mesenchymal stem cells (MSC) are crucial for therapy, with numerous clinical trials underway.
• Current MSC sources require invasive procedures and exhibit donor variability.
• Embryonic stem cell-derived MSC (ESC-MSC) offer a potential alternative, but their comparability to traditional MSC is unclear.

Purpose of the Study:

• To comprehensively characterize human ESC-MSC.
• To compare ESC-MSC with human bone marrow-derived MSC (BM-MSC) and human embryonic stem cells (hESC).
• To assess the therapeutic potential and molecular equivalency of ESC-MSC.

Main Methods:

• Transcriptomic analysis using RNA-sequencing (RNA-seq).
• Quantitative proteomic analysis using nanoLC-MS/MS with SILAC.
• Data integration and enrichment analysis.

Main Results:

• Identified vesicle-mediated transport and exosomes as central to MSC biology.
• Demonstrated broad application potential and versatility of MSC.
• Found ESC-MSC molecular profiles comparable to BM-MSC, with differences similar to MSC from other origins.
• Reported extensive coverage of MSC CD markers and membrane proteins.

Conclusions:

• ESC-MSC represent a viable alternative source for therapeutic applications.
• The molecular data supports the use of ESC-MSC in regenerative medicine.
• Detailed molecular profiles enhance understanding of MSC and aid immunofluorescence applications.